It was done at the "Max-Planck-Institut für Molekulare Zellbiologie und Genetik" (MPI-CBG) in Dresden and the "Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie" (HPI) in Hamburg. Tthe involved scientists expect practical relevance (medications) not before ten years (at the earliest).
The resulting drugs, as it seems now, also will be very expensive, which means that most patients around the world will not be able to afford them.
__________________
If you feel nuts, consult an expert.
|